A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study is aimed to evaluate the efficacy and safety of sintilimab combined with chemotherapy versus chemotherapy in perioperative treatment of locally advanced esophageal squamous cell carcinoma.
Epistemonikos ID: 2492e03e96e7b48baa64ec0992864182bf0b83a1
First added on: May 15, 2024